ipratropiumfuroaatti
Ipratropiumfuroaatti is a chemical compound and a salt of ipratropium. Ipratropium is a quaternary ammonium compound, specifically an anticholinergic bronchodilator. It is primarily used in the treatment of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. When ipratropium is combined with furoic acid, it forms ipratropiumfuroaatti.
The pharmacological action of ipratropium involves blocking muscarinic acetylcholine receptors in the airways. This action inhibits
Ipratropiumfuroaatti, as a salt form, is typically formulated into inhalable medications, commonly delivered via metered-dose inhalers